Esophageal brush: Candida albicans – Shipped November 4, 2019 FINAL RESULT.
A simulated esophageal brush swab collected from a 41 year old liver transplant patient with dysphagia was sent to category A laboratories.
Participants were expected to isolate and identify Candida albicans.
MAIN EDUCATIONAL POINTS from M193-5
- Esophageal candidiasis may arise as an opportunistic infection in persons with impaired cellular immunity (e.g., HIV infection), immunosuppression (e.g., transplant patients) or other chronic debilitating states (e.g., carcinoma), uncontrolled diabetes mellitus, or gastric acid suppression (e.g., proton pump inhibitors, H2-receptor antagonists, vagotomy) as well as in patients receiving systemic or inhaled corticosteroids, antibiotics, or immunosuppressive agents.
- Patients with esophageal candidiasis may present with one or more of the classic symptoms of infectious esophagitis (i.e., dysphagia, odynophagia, and chest pain).